tirzepatide summit trial Reaching the SUMMIT? Benefits and potential risks associated with the use of in heart failure with preserved ejection fraction SUMMIT: Tirzepatide Improves Outcomes and

And if a decision is made by a provider to combine the two agents, it is important to exercise caution and monitor therapy, say Drs

Some patients report that consistent daily ginger supplements, vitamin B6, or acupressure bands worn on the wrist reduce nausea without requiring pharmaceutical intervention

To explore if a GLP-1 medication is suitable for you, we encourage you to take our free assessment quiz

Week 48: Phase 2 Results Kept Building At 48 weeks in the same Phase 2 trial, the least-squares mean body-weight change was 17.1% in the combined 4 mg group, 22.8% in the combined 8 mg group, and 24.2% in the 12 mg group, compared with 2.1% for placebo